Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tissue Plasminogen Activator”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05491356
What this trial is testing

Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas

Who this might be right for
Hematoma, SubduralFibrinolytic; Hemorrhage
Hamilton Health Sciences Corporation 40
Testing effectiveness (Phase 2)Study completedNCT04256473
What this trial is testing

Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke

Who this might be right for
Ischemic Stroke
Erasmus Medical Center 200
Not applicableLooking for participantsNCT07419997
What this trial is testing

A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke

Who this might be right for
Stroke
Xuanwu Hospital, Beijing 2,600
Testing effectiveness (Phase 2)Study completedNCT00250991
What this trial is testing

Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial

Who this might be right for
Stroke
University of Cincinnati 94
Post-approval studies (Phase 4)Not Yet RecruitingNCT07816978
What this trial is testing

Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary Embolism

Who this might be right for
Pulmonary Embolism Acute
Sahlgrenska University Hospital 400
Post-approval studies (Phase 4)UnknownNCT02029456
What this trial is testing

Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05862805
What this trial is testing

PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis

Who this might be right for
Menstrual Bleeding, Heavy
Oregon Health and Science University 70
Not applicableStudy completedNCT01331200
What this trial is testing

Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-Tissue Plasminogen Activator (IV-tPA)

Who this might be right for
Ischemic Stroke
Mayo Clinic 20
Large-scale testing (Phase 3)Study completedNCT05601999
What this trial is testing

Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction

Who this might be right for
ST Elevation Myocardial Infarction
AO GENERIUM 244
Not applicableStudy completedNCT03247036
What this trial is testing

Long-Term Survival After Ischaemic Stroke: Ebrictus Study

Who this might be right for
Ischemic StrokeThrombolytic (t-PA) TreatmentGender Bias+1 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 21,000
Large-scale testing (Phase 3)Study completedNCT00147316
What this trial is testing

Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

Who this might be right for
Cerebral InfarctionBrain Ischemia
Tanabe Pharma Corporation 103
Post-approval studies (Phase 4)Study completedNCT00412867
What this trial is testing

Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

Who this might be right for
Stroke
Tanabe Pharma Corporation 58
Post-approval studies (Phase 4)Study completedNCT01246453
What this trial is testing

Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema

Who this might be right for
Empyema, PleuralPleural EffusionPleural Diseases
Hospital Universitari Vall d'Hebron Research Institute 204
Not applicableStudy completedNCT06018181
What this trial is testing

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

Who this might be right for
Ischemic Stroke, Acute
Dongzhimen Hospital, Beijing 2,408
Large-scale testing (Phase 3)Study completedNCT00385931
What this trial is testing

Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

Who this might be right for
HypertensionHypercholesterolemiaDyslipidemia
Novartis 412
Testing effectiveness (Phase 2)Study completedNCT01977456
What this trial is testing

Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)

Who this might be right for
StrokeBrain Infarction
Arthur Pancioli 27
Post-approval studies (Phase 4)UnknownNCT01531829
What this trial is testing

Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD

Who this might be right for
Pulmonary ThromboembolismsPulmonary Embolism
Beijing Chao Yang Hospital 460
Testing effectiveness (Phase 2)Study completedNCT02222714
What this trial is testing

Safety Evaluation of 3K3A-APC in Ischemic Stroke

Who this might be right for
Ischemic Stroke
ZZ Biotech, LLC 110
Early research (Phase 1)Study completedNCT00001713
What this trial is testing

Treatment for Blood Clots in the Veins of the Legs

Who this might be right for
EmbolismThrombophlebitis
National Institutes of Health Clinical Center (CC) 20
Large-scale testing (Phase 3)Study completedNCT02930837
What this trial is testing

Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset

Who this might be right for
Stroke
Boehringer Ingelheim 120
Next Page